ArticleAngewandte Chemie (International ed. in English)2026
Enzyme-Guided Assembly Enables Precision Delivery of a Singlet Oxygen Battery for Membrane Lipid Peroxidation Therapy.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Lipid peroxidation (LPO) of tumor cell membranes is a pivotal executor of regulated cell death and a potent trigger for antitumor immunity. However, most LPO inducing strategies either depend on external irradiation and adequate oxygen supply or require broad disruption of the glutathione (GSH)/glutathione peroxidase 4 (GPX4) antioxidant axis. As a result, their performance is often compromised by limited tissue penetration, heterogeneous tumor microenvironments, insufficient tumor selectivity with potential off target toxicity, and adaptive anti-ferroptotic responses that blunt sustained LPO amplification. To address these challenges, we developed a precision enhanced singlet oxygen battery (SOB), termed GUIDE-SOB. By integrating tumor-specific recognition with enzyme guided, cell-associated self-assembly, GUIDE-SOB achieves spatiotemporally confined oxidative therapy. This design anchors the oxidative source on the plasma membrane for more than 12 h and concentrates oxidative flux onto lipid rich membrane domains that are highly susceptible to peroxidation. Sustained membrane oxidation reduces reliance on light penetration and alleviates hypoxia associated limitations, while overcoming cellular repair mechanisms to produce robust tumor suppression. Overall, this work establishes a membrane-targeted oxidative platform with prolonged activity, providing a promising strategy for treating deep-seated and therapy-resistant malignancies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.